Features of course and prevalence of COVID-19 among cancer patients in different countries

Abstract

Relevance. SARS-CoV-2 and the disease it caused, COVID-19, became the reason of pandemic that changed the entire life of mankind once and for all. In the fist months, due to the lack of reliable data on this virus, experts could not even imagine how this situation would affect cancer patients. With the accumulation of experience in working with these patients in the conditions of the COVID-19 pandemic, articles summarizing information about the incidence of new coronavirus infection (NCI) and its course in cancer patients began to appear in medical publications. Up-to-date information on this topic is presented in this review.Target. The study of the prevalence and features of the course of COVID-19 based on the analysis of current scientifi publications on this topic.Results. The course of COVID-19 depends on many factors, including age, gender, comorbidity, ECOG status, recent cytotoxic chemotherapy, and the type of solid tumor.Conclusions. Due to the absence of a register of the incidence of COVID-19 in Russia, cancer patients do not have a complete understanding of how the tumor process proceeds after recovery from NCI. This requires further research and in-depth analysis.